BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22941468)

  • 1. Differential gene expression of Wnt signaling pathway in benign, premalignant, and malignant human breast epithelial cells.
    Wang YZ; Han YS; Ma YS; Jiang JJ; Chen ZX; Wang YC; Che W; Zhang F; Xia Q; Wang XF
    Tumour Biol; 2012 Dec; 33(6):2317-27. PubMed ID: 22941468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines.
    Kadota M; Yang HH; Gomez B; Sato M; Clifford RJ; Meerzaman D; Dunn BK; Wakefield LM; Lee MP
    PLoS One; 2010 Feb; 5(2):e9201. PubMed ID: 20169162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal changes in gene expression profiles of cocultured breast epithelial cells and primary fibroblasts.
    Rozenchan PB; Carraro DM; Brentani H; de Carvalho Mota LD; Bastos EP; e Ferreira EN; Torres CH; Katayama ML; Roela RA; Lyra EC; Soares FA; Folgueira MA; Góes JC; Brentani MM
    Int J Cancer; 2009 Dec; 125(12):2767-77. PubMed ID: 19530251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.
    Fu DY; Tan HS; Wei JL; Zhu CR; Jiang JX; Zhu YX; Cai FL; Chong MH; Ren CL
    Tumour Biol; 2015 Sep; 36(10):8025-34. PubMed ID: 25971583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
    McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM
    Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fresh surgical specimens yield breast stem/progenitor cells and reveal their oncogenic abnormalities.
    Pommier SJ; Hernandez A; Han E; Massimino K; Muller P; Diggs B; Chamberlain E; Murphy J; Hansen J; Naik A; Vetto J; Pommier RF
    Ann Surg Oncol; 2012 Feb; 19(2):527-35. PubMed ID: 21748247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pathway-based approach for identifying biomarkers of tumor progression to trastuzumab-resistant breast cancer.
    Nam S; Chang HR; Jung HR; Gim Y; Kim NY; Grailhe R; Seo HR; Park HS; Balch C; Lee J; Park I; Jung SY; Jeong KC; Powis G; Liang H; Lee ES; Ro J; Kim YH
    Cancer Lett; 2015 Jan; 356(2 Pt B):880-90. PubMed ID: 25449779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.
    Bhat-Nakshatri P; Appaiah H; Ballas C; Pick-Franke P; Goulet R; Badve S; Srour EF; Nakshatri H
    BMC Cancer; 2010 Aug; 10():411. PubMed ID: 20691079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models.
    Dunlap SM; Chiao LJ; Nogueira L; Usary J; Perou CM; Varticovski L; Hursting SD
    Cancer Prev Res (Phila); 2012 Jul; 5(7):930-42. PubMed ID: 22588949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer.
    Ray PS; Wang J; Qu Y; Sim MS; Shamonki J; Bagaria SP; Ye X; Liu B; Elashoff D; Hoon DS; Walter MA; Martens JW; Richardson AL; Giuliano AE; Cui X
    Cancer Res; 2010 May; 70(10):3870-6. PubMed ID: 20406990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low spinophilin expression enhances aggressive biological behavior of breast cancer.
    Schwarzenbacher D; Stiegelbauer V; Deutsch A; Ress AL; Aigelsreiter A; Schauer S; Wagner K; Langsenlehner T; Resel M; Gerger A; Ling H; Ivan C; Calin GA; Hoefler G; Rinner B; Pichler M
    Oncotarget; 2015 May; 6(13):11191-202. PubMed ID: 25857299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.
    Kim KH; Seol HJ; Kim EH; Rheey J; Jin HJ; Lee Y; Joo KM; Lee J; Nam DH
    Neuro Oncol; 2013 Feb; 15(2):161-71. PubMed ID: 23258844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis.
    Klemm F; Bleckmann A; Siam L; Chuang HN; Rietkötter E; Behme D; Schulz M; Schaffrinski M; Schindler S; Trümper L; Kramer F; Beissbarth T; Stadelmann C; Binder C; Pukrop T
    Carcinogenesis; 2011 Mar; 32(3):434-42. PubMed ID: 21173432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation factor VII is regulated by androgen receptor in breast cancer.
    Naderi A
    Exp Cell Res; 2015 Feb; 331(1):239-250. PubMed ID: 25447311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.
    Lopes N; Sousa B; Martins D; Gomes M; Vieira D; Veronese LA; Milanezi F; Paredes J; Costa JL; Schmitt F
    BMC Cancer; 2010 Sep; 10():483. PubMed ID: 20831823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
    Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
    Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis.
    Li JY; Zhang Y; Zhang WH; Jia S; Kang Y; Tian R
    Asian Pac J Cancer Prev; 2013; 14(3):1715-20. PubMed ID: 23679262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology.
    Pello OM; De Pizzol M; Mirolo M; Soucek L; Zammataro L; Amabile A; Doni A; Nebuloni M; Swigart LB; Evan GI; Mantovani A; Locati M
    Blood; 2012 Jan; 119(2):411-21. PubMed ID: 22067385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERBB2 overexpression triggers transient high mechanoactivity of breast tumor cells.
    Martin M; Müller K; Cadenas C; Hermes M; Zink M; Hengstler JG; Käs JA
    Cytoskeleton (Hoboken); 2012 May; 69(5):267-77. PubMed ID: 22407943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling changes induced by a novel Gemini Vitamin D derivative during the progression of breast cancer.
    Lee HJ; Liu H; Goodman C; Ji Y; Maehr H; Uskokovic M; Notterman D; Reiss M; Suh N
    Biochem Pharmacol; 2006 Jul; 72(3):332-43. PubMed ID: 16737686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.